Dowling & Yahnke’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,000
| Closed | -$79K | – | 389 |
|
|
2021
Q3 | $79K | Hold |
16,000
| – | – | ﹤0.01% | 367 |
|
|
2021
Q2 | $84K | Buy |
16,000
+3,000
| +23% | +$15.8K | ﹤0.01% | 364 |
|
|
2021
Q1 | $62K | Hold |
13,000
| – | – | ﹤0.01% | 336 |
|
|
2020
Q4 | $56K | Hold |
13,000
| – | – | ﹤0.01% | 325 |
|
|
2020
Q3 | $54K | Hold |
13,000
| – | – | ﹤0.01% | 304 |
|
|
2020
Q2 | $33K | Hold |
13,000
| – | – | ﹤0.01% | 292 |
|
|
2020
Q1 | $38K | Hold |
13,000
| – | – | ﹤0.01% | 286 |
|
|
2019
Q4 | $49K | Hold |
13,000
| – | – | ﹤0.01% | 321 |
|
|
2019
Q3 | $66K | Buy |
+13,000
| New | +$66K | 0.01% | 301 |
|